KEVIN J KEMPF MD NPI 1003895020

NPI Details

Kevin J Kempf, MD is a rheumatology internal medicine in San Antonio, TX with 35 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Kevin J Kempf, MD NPI is 1003895020. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: BAYLOR COLLEGE OF MEDICINE
Graduation Year:1991

The provider's business location address is:

19272 STONE OAK PKWY
STE 101
SAN ANTONIO, TX
ZIP 78258-371
Phone: (210) 265-8851
Fax: (210) 265-8855

The NPI 1003895020 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg (HCPCS:J3304)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Vitamin d-3 level (HCPCS:82306)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Rheumatoid factor level (HCPCS:86431)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
• Measurement of dna antibody, native or double stranded (HCPCS:86225)
• Measurement of dna antibody, single stranded (HCPCS:86226)
• Cardiolipin antibody (tissue antibody) measurement (HCPCS:86147)
• Beta 2 glycoprotein 1 antibody (autoantibody) measurement (HCPCS:86146)
• Measurement of substance using immunoassay technique (HCPCS:83520)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose (HCPCS:J7323)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• Uric acid level, blood (HCPCS:84550)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Folic acid level, serum (HCPCS:82746)
• Iron binding capacity (HCPCS:83550)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Injection, methylprednisolone acetate, 20 mg (HCPCS:J1020)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)

The enumeration date for this NPI number is 1/10/2006 and was last updated on 7/29/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.